Comparative Effectiveness of the Bivalent (Original/Omicron BA.4/BA.5) mRNA COVID-19 Vaccines mRNA-1273.222 and BNT162b2 Bivalent in Adults With Underlying Medical Conditions in the United States

Hagit Kopel, Van Hung Nguyen, Alina Bogdanov, Isabelle Winer, Catherine Boileau, Thierry Ducruet, Ni Zeng, Jessamine Winer-Jones, Daina B. Esposito, Mary Bausch-Jurken, Ekkehard Beck, Mac Bonafede, James A. Mansi
doi: https://doi.org/10.1101/2024.08.06.24311559

Data Availability Statement

The data that support the findings of this study were used under license from Veradigm and Komodo Health. Due to data use agreements and its proprietary nature, restrictions apply regarding the availability of the data. Further information is available from the corresponding author.

Back to top
Posted August 07, 2024.
Download PDF
Data/Code
Email
Comparative Effectiveness of the Bivalent (Original/Omicron BA.4/BA.5) mRNA COVID-19 Vaccines mRNA-1273.222 and BNT162b2 Bivalent in Adults With Underlying Medical Conditions in the United States
Hagit Kopel, Van Hung Nguyen, Alina Bogdanov, Isabelle Winer, Catherine Boileau, Thierry Ducruet, Ni Zeng, Jessamine Winer-Jones, Daina B. Esposito, Mary Bausch-Jurken, Ekkehard Beck, Mac Bonafede, James A. Mansi
medRxiv 2024.08.06.24311559; doi: https://doi.org/10.1101/2024.08.06.24311559
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area